- Report
- March 2024
- 149 Pages
Global
From €4711EUR$4,950USD£3,955GBP
- Report
- October 2024
- 184 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 196 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 191 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 197 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 183 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- February 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- February 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- January 2024
- 200 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- February 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- November 2024
- 363 Pages
Global
From €5187EUR$5,450USD£4,354GBP
- Report
- August 2024
- 150 Pages
Global
From €4616EUR$4,850USD£3,875GBP
- Report
- May 2024
- 140 Pages
Global
From €6185EUR$6,499USD£5,192GBP
- Report
- May 2024
- 133 Pages
Global
From €6185EUR$6,499USD£5,192GBP
- Report
- May 2024
- 130 Pages
Global
From €6185EUR$6,499USD£5,192GBP
- Report
- May 2024
- 138 Pages
Global
From €6185EUR$6,499USD£5,192GBP
- Report
- April 2024
- 180 Pages
Global
From €4663EUR$4,900USD£3,915GBP
- Report
- June 2024
- 200 Pages
Global
From €7566EUR$7,950USD£6,351GBP
- Report
- June 2024
- 200 Pages
Global
From €7566EUR$7,950USD£6,351GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1190EUR$1,250USD£999GBP
The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells.
Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more